The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women

Heart

Volumn 102, Issue 17, 2016, Pages 1354-1362

  Ermakov, Simon ^a   Azarbal, Farnaz ^a   Stefanick, Marcia L ^a   Lamonte, Michael J ^b   Li, Wenjun ^c   Tharp, Katie M ^d   Martin, Lisa W ^e   Nassir, Rami ^f   Salmoirago Blotcher, Elena ^c   Albert, Christine M ^g   Manson, Joann E ^g   Assimes, Themistocles L ^a   Hlatky, Mark A ^a   Larson, Joseph C ^a   Perez, Marco V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; RESISTIN; ADIPOQ PROTEIN, HUMAN; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; RETN PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; ETHNOLOGY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; UNITED STATES;

ADIPONECTIN; AGED; ATRIAL FIBRILLATION; BIOMARKERS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CYTOKINES; FEMALE; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; LEPTIN; LINEAR MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESISTIN; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84966431084     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308927     Document Type: Article

References (32)

1. Naccarelli GV, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104: 1534-9.
2. Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998; 158: 229-34.
3. Friberg J, Scharling H, Gadsbøll N, et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 2004; 94: 889-94.
4. Perez MV, Wang PJ, Larson JC, et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study. Heart 2013; 99: 1173-8.
5. Wanahita N, Messerli FH, Bangalore S, et al. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 2008; 155: 310-15.
6. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101: 545-59.
7. Lee SE, Kim HS. Human resistin in cardiovascular disease. J Smooth Muscle Res 2012; 48: 27-35.
8. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
9. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003; 13(9 Suppl): S122-8.
10. Anderson G, Cummings S, Freedman LS, et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998; 19: 61-109.
11. Wang L, Manson JE, Gaziano JM, et al. Plasma adiponectin and the risk of hypertension in White and black postmenopausal women. Clin Chem 2012; 58: 1438-45.
12. Wang T, Rohan TE, Gunter MJ, et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone Nonusers. Cancer Epidemiol Biomarkers Prev 2011; 20: 971-7.
13. Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative. Stroke 2011; 42: 1813-20.
14. Ho GY, Wang T, Gunter MJ, et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res 2012; 72: 3029-37.
15. Khan UI, Ogorodnikova AD, Xu L, et al. The adipokine profile of metabolically benign obese and at-risk normal weight postmenopausal women: the Women's Health Initiative Observational Study. Obesity (Silver Spring) 2014; 22: 786-94.
16. Kaplan RC, Ho GY, Xue X, et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 2007; 16: 1291-3.
17. Kaplan RC, McGinn AP, Baird AE, et al. Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. J Stroke Cerebrovasc Dis 2008; 17: 344-55.
18. Abed HS, Wittert GA. Obesity and atrial fibrillation. Obes Rev 2013; 14: 929-38.
19. Gungor H, Ayik MF, Kirilmaz B, et al. Serum resistin level: as a predictor of atrial fibrillation after coronary artery bypass graft surgery. Coron Artery Dis 2011; 22: 484-90.
20. Rienstra M, Sun JX, Lubitz SA, et al. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J 2012; 163: 119-24.
21. Özcan KS, Güngör B, Altay S, et al. Increased level of resistin predicts development of atrial fibrillation. J Cardiol 2014; 63: 308-12.
22. Muse ED, Feldman DI, Blaha MJ, et al. The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2015; 239: 101-8.
23. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
24. Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 2006; 3: 29-34.
25. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60: 2263-70.
26. Lin YK, Chen YC, Chen JH, et al. Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation. Basic Res Cardiol 2012; 107: 293.
27. Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014; 64: 281-9.
28. Pravdová E, Macho L, Hlavácová N, et al. Long-time alcohol intake modifies resistin secretion and expression of resistin gene in adipose tissue. Gen Physiol Biophys 2007; 26: 221-9.
29. Hillemacher T, Weinland C, Heberlein A, et al. Increased levels of adiponectin and resistin in alcohol dependence-possible link to craving. Drug Alcohol Depend 2009; 99: 333-7.
30. Shimano M, Shibata R, Tsuji Y, et al. Circulating adiponectin levels in patients with atrial fibrillation. Circ J 2008; 72: 1120-4.
31. Choi BJ, Heo JH, Choi IS, et al. Hypoadiponectinemia in patients with paroxysmal atrial fibrillation. Korean Circ J 2012; 42: 668-73.
32. Fukui A, Takahashi N, Nakada C, et al. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Circ Arrhythm Electrophysiol 2013; 6: 402-9.